ブックタイトルHealth Management for Female Athletes

概要

Health Management for Female Athletes

27. Peters C and Burrows M. Androgenicity of the progestin in oral contraceptives does not affectmaximal leg strength. Contraception, 74(6), 487-491, 2006.28. Ekenros L et al. Oral contraceptives do not affect muscle strength and hop performance in activewomen. Clin J Sport Med, 23(3), 202-207, 2003.29. Giacomoni M et al. Influence of the menstrual cycle phase and menstrual symptoms on maximalanaerobic performance. Med Sci Sports Exerc, 32(2), 486-492, 2000.30. Rechichi C and Dawson B. Effect of oral contraceptive cycle phase on performance in team sportplayers. J Sci Med Sport, 12(1), 190-195, 2009.31. Bushman B et al. Anaerobic power performance and the menstrual cycle: eumenorrheic and oralcontraceptive users. J Sports Med Phys Fitness, 46(1),132-137, 2006.32. Renstrom P et al. Non-contact ACL injuries in female athletes: an International OlympicCommittee current concepts statement. Br J Sports Med, 42(6), 394-412, 2008.33. Heitz NA et al. Hormonal changes throughout the menstrual cycle and increased anterior cruciateligament laxity in females. J Athl Train, 34(2), 144-149, 1999.34. Park SK et al. Alterations in knee joint laxity during the menstrual cycle in healthy women leadsto increases in joint loads during selected athletic movements. Am J Sports Med, 37(6), 1169-1177,2009.35. Dragoo JL et al. Relaxin receptors in the human female anterior cruciate ligament. Am J SportsMed, 31(4), 577-584,2003.36. Dragoo JL et al. Prospective correlation between serum relaxin concentration and anteriorcruciate ligament tears among elite collegiate female athletes. Am J Sports Med, 39(10), 2175-2180, 2011.37. Dragoo JL et al. Trends in serum relaxin concentration among elite collegiate female athletes. IntJ Womens Health, 19(3), 19-24, 2011.38. Nose-Ogura S et al. Oral contraceptive therapy reduces serum relaxin-2 in elite female athletes. JObstet Gynaecol Res, 2016.39. Rechichi C et al. Athletic performance and the oral contraceptive. Int J Sports Physiol Perform,4(2), 51-62, 2009.40.プリンシプル産科婦人科学１婦人科編メジカルビュー, p106, 2014.41.プリンシプル産科婦人科学１婦人科編メジカルビュー, p241, 2014.42. De Souza MJ et al. 2014 Female Athlete Triad Coalition Consensus Statement on Treatment andReturn to Play of the Female Athlete Triad: 1st International Conference held in San Francisco,California, May 2012 and 2nd International Conference held in Indianapolis, Indiana, May 2013,Br J Sports Med, 48(4), 289, 2014.43. Joy E et al. 2016 update on eating disorders in athletes: A comprehensive narrative review with afocus on clinical assessment and management. Br J Sports Med, 50(3), 154-62, 2016.44. Loucks AB et al. Luteinizing hormone pulsatility is disrupted at a threshold of energy availabilityin regularly menstruating women. J Clin Endocrinol Metab, 88(1), 297-311, 2014.45. Tenforde AS et al. Association of the Female Athlete Triad Risk Assessment Stratification to theDevelopment of Bone Stress Injuries in Collegiate Athletes. Am J Sports Med, 45(2), 302-310,2017.46. Goolsby MA. Bone Health in Athletes. Sports Health, 9(2), 108-117, 2017.47. Mountjoy M et al. The IOC consensus statement: beyond the Female Athlete Triad--RelativeEnergy Deficiency in Sport (RED-S). Br J Sports Med, 48(7), 491-7, 2014.48. Mallinson RJ et al. Current perspectives on the etiology and manifestation of the "silent"component of the Female Athlete Triad. Int J Womens Health, (6), 451-67, 2014.49.能瀬さやから.スポーツと月経,小児科, 56(9), 1439-1445, 2015.159